J. Yang

发表

Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells

H. Koeffler, T. Ikezoe, Jing Yang, 2008, Leukemia.

PSGL-1/selectin and ICAM-1/CD18 interactions are involved in macrophage-induced drug resistance in myeloma

R. Davis, P. Qiu, L. Kwak, 2013, Leukemia.

Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications

Michael L. Wang, J. Yang, V. Baladandayuthapani, 2014, Leukemia.

Fludarabine induces apoptosis of human T-cell leukemia virus type 1-infected T cells via inhibition of the nuclear factor-κB signal pathway

H. Koeffler, T. Ikezoe, H. Taguchi, 2007, Leukemia.

Bortezomib is synergistic with rituximab and cyclophosphamide in inducing apoptosis of mantle cell lymphoma cells in vitro and in vivo

M. Wang, L. Kwak, J. Yang, 2008, Leukemia.

A novel treatment strategy targeting polo-like kinase 1 in hematological malignancies

H. Koeffler, T. Ikezoe, Jing Yang, 2009, Leukemia.

Thrombomodulin blocks calcineurin inhibitor-induced vascular permeability via inhibition of Src/VE-cadherin axis

T. Ikezoe, K. Umezawa, C. Nishioka, 2017, Bone Marrow Transplantation.

Tyrosine phosphorylation of Shc proteins in normal CD34+ progenitor cells and leukemic cells.

P. Venugopal, H. Preisler, J. Yang, 1999, Blood.

Cytokine gene activity in AML cells in vivo in patients.

P. Venugopal, H. Preisler, S. Bi, 1998, Leukemia research.

Poor prognosis acute myelogenous leukemia 2--biological and molecular biological characteristics and treatment outcome.

P. Venugopal, H. Preisler, J. Yang, 2000, Leukemia research.

Paclitaxel induces apoptosis in leukemia cells through a JNK activation-dependent pathway.

X. Wang, J. Yang, Z. Peng, 2016, Genetics and molecular research : GMR.

Inhibition of MEK/ERK signaling synergistically potentiates histone deacetylase inhibitor-induced growth arrest, apoptosis and acetylation of histone H3 on p21waf1 promoter in acute myelogenous leukemia cell

H. Koeffler, T. Ikezoe, C. Nishioka, 2008, Leukemia.

The significance of CD34 and TdT determinations in patients with untreated de novo acute myeloid leukemia.

J. Testa, J. Yang, C. Schiffer, 1992, Leukemia.

Poor prognosis acute myelogenous leukemia: 3--biological and molecular biological changes during remission induction therapy.

P. Venugopal, H. Preisler, J. Yang, 2001, Leukemia research.

Long-term exposure of leukemia cells to multi-targeted tyrosine kinase inhibitor induces activations of AKT, ERK and STAT5 signaling via epigenetic silencing of the PTEN gene

T. Ikezoe, Jing Yang, C. Nishioka, 2010, Leukemia.

High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients

Jf Yang, Y. Lin, J. Yang, 2017, Leukemia.

Imatinib causes epigenetic alterations of PTEN gene via upregulation of DNA methyltransferases and polycomb group proteins

T. Ikezoe, Jing Yang, C. Nishioka, 2011, Blood cancer journal.

Thrombomodulin alleviates murine GVHD in association with an increase in the proportion of regulatory T cells in the spleen

T. Ikezoe, C. Nishioka, A. Yokoyama, 2015, Bone Marrow Transplantation.

Mangiferin induces cell cycle arrest at G2/M phase through ATR-Chk1 pathway in HL-60 leukemia cells.

J. Yang, Z. Peng, X. Huang, 2015, Genetics and molecular research : GMR.

Immune Checkpoints of CD8+ T Cells in Acute Myeloid Leukemia

G. Liu, J. Yang, E. Shen, 2018 .

Multitargeted tyrosine kinase inhibitor stimulates expression of IL-6 and activates JAK2/STAT5 signaling in acute myelogenous leukemia cells

T. Ikezoe, C. Nishioka, A. Yokoyama, 2009, Leukemia.

Sunitinib, an orally available receptor tyrosine kinase inhibitor, induces monocytic differentiation of acute myelogenous leukemia cells that is enhanced by 1,25-dihydroxyvitamin D3

T. Ikezoe, C. Nishioka, A. Yokoyama, 2009, Leukemia.

Targeting the Pro-Survival Protein MET with Tivantinib (ARQ 197) Inhibits Growth of Multiple

R. Orlowski, C. M. Stellrecht, V. Gandhi, 2015 .

ZD6474 induces growth arrest and apoptosis of human leukemia cells, which is enhanced by concomitant use of a novel MEK inhibitor, AZD6244

H. Koeffler, N. Komatsu, Y. Yang, 2007, Leukemia.